Goodwin is undertaking a robust program to bring diversity into the boardroom. The effort was conceived and is managed by senior legal partners Stuart Cable and Lisa Haddad. Learn more in this video interview with The Directors Letter.
Related Content
- InsightApril 24, 2024
Healthcare M&A and Financing Trends and Predictions for 2024
- InsightApril 24, 2024
European Commission’s First-Ever Abuse of Dominance Probe for Shelving of a Novel Pipeline Therapy
- AlertApril 15, 2024
Delaware Supreme Court Holds That Boards Must Satisfy the MFW Framework in Controller Transactions to Obtain Business Judgment Deference
- NewslettersApril 4, 2024
SEC Adopts Reforms Relating to Investment Advisers Operating Exclusively Through the Internet
- Alert28 March 2024
At the Intersection of ‘S’ and ‘G’ of ESG: London Leading the Way on Board Diversity — An Update on Latest FTSE Women Leaders Review and Parker Review Reports
- NewslettersMarch 28, 2024
Agencies Extend Applicability Date of Certain Provisions of their CRA Final Rule
- NewslettersMarch 21, 2024
FinCEN Publishes an Administrative Ruling Regarding Customer Identification Program and Customer Due Diligence Requirements for Designated Beneficiaries of Individual Retirement Accounts
- NewslettersMarch 14, 2024
Federal Reserve Announces Final Rule Updating Risk Management Requirements for Certain Systemically Important Financial Market Utilities
- Speaking EngagementsMay 14, 2024
What Tech Companies Need to Know: State of Tech M&A Panel
- Press ReleaseApril 11, 2024
Digital Markets Guide: US Skepticism of Tech Transactions Sparks a Step-Up in Merger Enforcement (GCR)
- Press ReleaseApril 10, 2024
Alpine Immune Sciences To Be Acquired by Vertex Pharmaceuticals For $4.9 Billion
- Press ReleaseApril 10, 2024
Auradine Raises $80 Million in Series B Financing and Achieves $80 Million in Bookings
- In the PressApril 9, 2024
Deal Watch: M&A (Law.com)
- In the PressApril 4, 2024
US Law Firms Ride Rising M&A Wave in Q1 (Reuters)
- In the PressApril 4, 2024
Q1 PE League Tables: Making it Private (The Deal)
- Press ReleaseApril 3, 2024
AlmataBio Acquired by Avalo Therapeutics For $22.5 Million